VITASPRING BIOMEDICAL CO., LTD. Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $0.00 per share as of 2025-01-31, per its 10-K filed 2026-06-08.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-06-08
- 2025-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.00.
- 2024-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.00.
- 2024-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.01.
- 2024-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $0.01.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price |
|---|---|
| 2025-01-31 | $0.00 10-K · filed 2026-06-08 |
| 2024-10-31 | $0.00 10-Q · filed 2026-05-06 |
| 2024-07-31 | $0.01 10-Q · filed 2026-04-22 |
| 2024-04-30 | $0.01 10-Q · filed 2026-04-02 |
| 2024-01-31 | $0.01 10-K · filed 2026-06-08 |
| 2023-10-31 | $0.01 10-Q · filed 2026-01-30 |
| 2023-07-31 | $0.01 10-Q · filed 2026-01-23 |
| 2023-04-30 | $0.01 10-Q · filed 2026-01-13 |
| 2023-01-31 | $0.01 10-K · filed 2026-06-08 |
| 2022-01-31 | $0.01 10-K · filed 2026-03-12 |